Derazantinib
Derazantinib Uses, Dosage, Side Effects, Food Interaction and all others data.
Derazantinib is under investigation in clinical trial NCT03230318 (Derazantinib in Subjects With FGFR2 Gene Fusion Positive Inoperable or Advanced Intrahepatic Cholangiocarcinoma).
| Trade Name | Derazantinib |
| Generic | Derazantinib |
| Derazantinib Other Names | Derazantinib |
| Type | |
| Formula | C29H29FN4O |
| Weight | Average: 468.576 Monoisotopic: 468.232539733 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Derazantinib
